Healthium Medtech Limited is a global medical devices company focused on products used in surgical, post-surgical and chronic care. Fuelled by its vision to provide “Access to precision medtech for every patient, globally," it is present across 80 countries. 1 in 5 surgeries conducted globally, uses a Healthium product . As of Fiscal Year 2021, Healthium Medtech is the largest independent medical devices company in India and 2nd largest in the surgical consumables market, the largest non-captive surgical needles manufacturer globally by volume . Healthium is driving Innovation by focusing on R & D. Since fiscal year 2018, it has sold 30 new products. It holds 35 patents in U.S, Europe and India and 29 pending patent applications . It has 8 high precision, integrated manufacturing facilities with global certifications like US FDA, C.E and ISO. DISCLAIMER: “Healthium Medtech Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India. The DRHP is available on the website of the SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, CLSA India Private Limited, Credit Suisse Securities (India) Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at www.icicisecurities.com, www.india.clsa.com, www.credit-suisse.com and www.nomuraholdings.com/ company/group/asia/india/index.html, respectively, and the websites of the stock exchange(s) at www.bseindia.com and www.nseindia.com, respectively. Any potential investor should note that investment in equity shares involves a involves a high degree of risk and for details relating to such risk, see "Risk Factors" of the RHP / Prospectus, when available. Potential investors should not rely on the DRHP for any investment decision"